Cayman Chemical Receives CEP for Latanoprost API from EDQM

Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients (APIs), has been granted a CEP for its latanoprost API. Cayman Chemical is the first company in the USA to receive a CEP for latanoprost. ANN ARBOR, Mich.,...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news